S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Will NIO Partake In China's Economic Awakening?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
How to Choose a Brokerage Account or Online Broker
Tax Software Specialist Vertex In Buy Zone After Base Breakout
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
What is a Mutual Fund? How Does it Work?
Will Plug Power’s Deal With Energy Vault Move The Needle? 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Will NIO Partake In China's Economic Awakening?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
How to Choose a Brokerage Account or Online Broker
Tax Software Specialist Vertex In Buy Zone After Base Breakout
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
What is a Mutual Fund? How Does it Work?
Will Plug Power’s Deal With Energy Vault Move The Needle? 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Will NIO Partake In China's Economic Awakening?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
How to Choose a Brokerage Account or Online Broker
Tax Software Specialist Vertex In Buy Zone After Base Breakout
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
What is a Mutual Fund? How Does it Work?
Will Plug Power’s Deal With Energy Vault Move The Needle? 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Will NIO Partake In China's Economic Awakening?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
How to Choose a Brokerage Account or Online Broker
Tax Software Specialist Vertex In Buy Zone After Base Breakout
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
What is a Mutual Fund? How Does it Work?
Will Plug Power’s Deal With Energy Vault Move The Needle? 
TSE:AND

Andlauer Healthcare Group (AND) Price Target & Analyst Ratings

C$44.40
-0.28 (-0.63%)
(As of 06/9/2023 ET)
Compare
Today's Range
C$43.78
C$44.50
50-Day Range
C$44.40
C$52.05
52-Week Range
C$37.57
C$55.97
Volume
13,922 shs
Average Volume
20,794 shs
Market Capitalization
C$891.11 million
P/E Ratio
24.80
Dividend Yield
0.72%
Price Target
C$56.68

Andlauer Healthcare Group Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 5 Analyst Ratings

Consensus Analyst Price Target

C$55.96
26.05% Upside
High PredictionC$65.00
Average PredictionC$55.96
Low PredictionC$46.00
TypeCurrent
6/10/22 to 6/10/23
1 Month Ago
5/11/22 to 5/11/23
3 Months Ago
3/12/22 to 3/12/23
1 Year Ago
6/10/21 to 6/10/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
0 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetC$55.96C$56.68C$57.43C$49.75
Predicted Upside26.05% Upside18.78% Upside15.58% Upside9.43% Upside
Get Andlauer Healthcare Group Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AND and its competitors with MarketBeat's FREE daily newsletter.


AND Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AND Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Andlauer Healthcare Group Stock vs. The Competition

TypeAndlauer Healthcare GroupMedical Companies
Consensus Rating Score
2.40
2.66
Consensus RatingHoldBuy
News Sentiment RatingNeutral News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/9/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$51.00 ➝ C$46.00+4.24%
5/8/2023Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$55.00 ➝ C$52.00+11.37%
5/5/2023National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperformC$60.00 ➝ C$58.75+26.48%
5/5/2023CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$54.00 ➝ C$50.00+7.64%
3/6/2023TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHoldC$57.00 ➝ C$58.00+18.78%
1/17/2023Eight Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Set TargetBuyC$62.00+32.56%
8/11/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetC$55.00 ➝ C$65.00+19.57%
7/11/2022National Bank Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
E. Leno
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Perform Market Weight ➝ Outperform Market Weight
(Data available from 6/10/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












AND Price Target - Frequently Asked Questions

What is Andlauer Healthcare Group's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for Andlauer Healthcare Group stock is Hold based on the current 3 hold ratings and 2 buy ratings for AND. The average twelve-month price prediction for Andlauer Healthcare Group is C$55.96 with a high price target of C$65.00 and a low price target of C$46.00. Learn more on AND's analyst rating history.

Do Wall Street analysts like Andlauer Healthcare Group more than its competitors?

Analysts like Andlauer Healthcare Group less than other Medical companies. The consensus rating for Andlauer Healthcare Group is Hold while the average consensus rating for medical companies is Buy. Learn more on how AND compares to other companies.

Does Andlauer Healthcare Group's stock price have much upside?

According to analysts, Andlauer Healthcare Group's stock has a predicted upside of 17.76% based on their 12-month price targets.

What analysts cover Andlauer Healthcare Group?

Andlauer Healthcare Group has been rated by CIBC, National Bankshares, Royal Bank of Canada, and Scotiabank in the past 90 days.


Stock Ratings Reports and Tools

This page (TSE:AND) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -